Leukemia & Lymphoma Society | Advocacy Groups

The Leukemia & Lymphoma Society (LLS) exists to find cures and ensure access to the best available treatments for blood cancer patients. LLS is the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. LLS has chapters throughout the country and in Canada.

Latest from Leukemia & Lymphoma Society

CURE® Speaking Out Video Series Supports Blood Cancer Awareness Month and World Lymphoma Awareness Day

September 10, 2020

Article

Susan M. O’Brien, M.D., one of the nation’s foremost leukemia experts, discusses the future of frontline therapies and upcoming clinical trials associated with chronic lymphocytic leukemia.

Understanding Chronic Lymphocytic Leukemia

August 25, 2020

Video

CURE speaks with Dr. Susan O'Brien, on behalf of the Leukemia and Lymphoma Society.

Friday Frontline: Cancer Updates, Research and Education on June 12, 2020

June 12, 2020

Article

From the American Cancer Society laying off 1,000 employees due to the economic impact of COVID-19 to former Senate Majority Leader Harry Reid announcing his cancer is in remission after receiving an experimental treatment, here’s what’s making the headlines in the cancer space this week.

How One Organization is Helping Patients with Blood Cancers Through the COVID-19 Pandemic

April 22, 2020

Video

Patients with blood cancers are facing unprecedented challenges to their treatment journeys as the COVID-19 pandemic continues to disrupt the cancer landscape. Which is why the Leukemia and Lymphoma Society is looking to offer its own lifeline to patients.

Your Questions Answered About Coronavirus (COVID-19)

April 02, 2020

Article

Two hematologist/oncologists on the LLS leadership team, and experts in the field of blood cancer, answer questions and concerns about coronavirus (COVID-19).

Speaking Out: Treatment Options May Expand in Mantle Cell Lymphoma

March 05, 2020

Article

An expert sheds light on the latest therapies in clinical trials and promising drug combinations to thwart the aggressive disease.